Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant

Area of Science:

• Immunology
• Synthetic Chemistry
• Vaccinology

Background:

• Complete Freund's Adjuvant (CFA) is a widely used immunological tool.
• CFA's efficacy is linked to its components derived from mycobacteria and mineral oil.
• The specific mycobacterial components responsible for CFA's adjuvant effect require elucidation.

Purpose of the Study:

• To identify and synthetically recapitulate the essential mycobacterial components of CFA.
• To develop a molecularly-defined adjuvant as a safer alternative to CFA.
• To investigate the role of N-glycolylated peptidoglycan and trehalose dimycolate in adjuvant activity.

Main Methods:

• Utilized knockout strains and chemical complementation to assess adjuvant component essentiality.
• Synthesized key mycobacterial molecules, including N-glycolyl muramyl dipeptide and GlcC14C18.
• Evaluated the effects of synthetic adjuvants on dendritic cell activation and experimental autoimmunity.

Main Results:

• Demonstrated the essentiality of N-glycolylated peptidoglycan and trehalose dimycolate for CFA's adjuvant effect.
• A synthetic combination of N-glycolyl muramyl dipeptide and GlcC14C18 upregulated dendritic cell effectors.
• The synthetic adjuvant induced experimental autoimmunity qualitatively similar but quantitatively milder than CFA.

Conclusions:

• Complete Freund's Adjuvant (CFA) can be replaced by a consistent, molecularly-defined synthetic adjuvant.
• This synthetic adjuvant comprises N-glycolylated peptidoglycan and trehalose dimycolate.
• Findings inform the design of immunotherapeutic agents and vaccines leveraging cell-mediated immunity and synthetic microbe-associated molecular patterns (MAMPs).